Date Name Title Filing Type Shares Traded Price Total Held
Mar 09, 2006
Director
Director Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 4,717 $16.76 5,283
Mar 09, 2006
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,000 -- --
Mar 08, 2006
Director, Chief Exec Officer & President, Ten Percent Owner
Director, Chief Exec Officer & President, Ten Percent Owner Form 4 Other acquisition or disposition -- -- 900
Mar 08, 2006
Director, Chief Exec Officer & President, Ten Percent Owner
Director, Chief Exec Officer & President, Ten Percent Owner Form 4 Other acquisition or disposition -- -- 900
Mar 07, 2006
Director, Chief Exec Officer & President, Ten Percent Owner
Director, Chief Exec Officer & President, Ten Percent Owner Form 4 Open market or private sale of non-derivative or derivative security 401 $18.00 121,665
Mar 06, 2006
Director, Chief Exec Officer & President, Ten Percent Owner
Director, Chief Exec Officer & President, Ten Percent Owner Form 4 Open market or private sale of non-derivative or derivative security 700 $18.00 122,066
Feb 08, 2006
Director
Director Form 4 Other acquisition or disposition -- -- 2,700
Feb 07, 2006
Director
Director Form 4 Conversion of derivative security 20,000 -- 35,258
Feb 07, 2006
Director
Director Form 4 Conversion of derivative security 20,000 -- 35,349
Feb 06, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Open market or private sale of non-derivative or derivative security 7,199 $16.00 4,527

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.